Recent advances in COL3A1 research include the use of CRISPR-Cas9 technology to edit the COL3A1 gene, which has potential therapeutic applications for correcting mutations associated with connective tissue disorders. Additionally, studies are exploring the role of COL3A1 in cancer, as altered collagen expression can influence tumor progression and metastasis.
